Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

The potential health effects of dietary phytoestrogens.

Rietjens IMCM, Louisse J, Beekmann K.

Br J Pharmacol. 2017 Jun;174(11):1263-1280. doi: 10.1111/bph.13622. Epub 2016 Oct 20. Review.

2.

Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells.

Shen M, Shi H.

PLoS One. 2016 Mar 16;11(3):e0151455. doi: 10.1371/journal.pone.0151455. eCollection 2016.

3.

Chinese herbal medicine for menopausal symptoms.

Zhu X, Liew Y, Liu ZL.

Cochrane Database Syst Rev. 2016 Mar 15;3:CD009023. doi: 10.1002/14651858.CD009023.pub2. Review.

4.

Long-term impact of preeclampsia on maternal endometrial cancer risk.

Hallum S, Pinborg A, Kamper-Jørgensen M.

Br J Cancer. 2016 Mar 29;114(7):809-12. doi: 10.1038/bjc.2016.55. Epub 2016 Mar 10.

5.

Identification of collaboration patterns of dysfunctional pathways in breast cancer.

Zhu X, Tao L, Yao J, Sun P, Pei L, Li J, Long Z, Wang Y, Zhang F.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):3853-64. eCollection 2014.

6.

Macrophage capping protein CapG is a putative oncogene involved in migration and invasiveness in ovarian carcinoma.

Glaser J, Neumann MH, Mei Q, Betz B, Seier N, Beyer I, Fehm T, Neubauer H, Niederacher D, Fleisch MC.

Biomed Res Int. 2014;2014:379847. doi: 10.1155/2014/379847. Epub 2014 Apr 2.

7.

Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls.

Wang W, Li JL, He XF, Li AP, Cai YL, Xu N, Sun SM, Wu BY.

PLoS One. 2013 Sep 9;8(9):e75153. doi: 10.1371/journal.pone.0075153. eCollection 2013.

8.

Associations between dietary acrylamide intake and plasma sex hormone levels.

Hogervorst JG, Fortner RT, Mucci LA, Tworoger SS, Eliassen AH, Hankinson SE, Wilson KM.

Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2024-36. doi: 10.1158/1055-9965.EPI-13-0509. Epub 2013 Aug 27.

9.
10.

Do reproductive factors influence T, N, and M classes of ductal and lobular breast cancers? A nation-wide follow-up study.

Mousavi SM, Försti A, Sundquist K, Hemminki K.

PLoS One. 2013 May 29;8(5):e58867. doi: 10.1371/journal.pone.0058867. Print 2013.

11.

Declining second primary ovarian cancer after first primary breast cancer.

Schonfeld SJ, Berrington de Gonzalez A, Visvanathan K, Pfeiffer RM, Anderson WF.

J Clin Oncol. 2013 Feb 20;31(6):738-43. doi: 10.1200/JCO.2012.43.2757. Epub 2013 Jan 2.

12.

Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study.

Brand JS, van der Schouw YT, Onland-Moret NC, Sharp SJ, Ong KK, Khaw KT, Ardanaz E, Amiano P, Boeing H, Chirlaque MD, Clavel-Chapelon F, Crowe FL, de Lauzon-Guillain B, Duell EJ, Fagherazzi G, Franks PW, Grioni S, Groop LC, Kaaks R, Key TJ, Nilsson PM, Overvad K, Palli D, Panico S, Quirós JR, Rolandsson O, Sacerdote C, Sánchez MJ, Slimani N, Teucher B, Tjonneland A, Tumino R, van der A DL, Feskens EJ, Langenberg C, Forouhi NG, Riboli E, Wareham NJ; InterAct Consortium.

Diabetes Care. 2013 Apr;36(4):1012-9. doi: 10.2337/dc12-1020. Epub 2012 Dec 10.

13.

Cooperating transcription factors mediate the function of estrogen receptor.

Fiorito E, Katika MR, Hurtado A.

Chromosoma. 2013 Mar;122(1-2):1-12. doi: 10.1007/s00412-012-0392-7. Epub 2012 Nov 29. Review.

14.

Association of overweight and obesity with breast cancer in India.

Singh P, Kapil U, Shukla N, Deo S, Dwivedi S.

Indian J Community Med. 2011 Oct;36(4):259-62. doi: 10.4103/0970-0218.91326.

15.

Regulation of immune cell function and differentiation by the NKG2D receptor.

Zafirova B, Wensveen FM, Gulin M, Polić B.

Cell Mol Life Sci. 2011 Nov;68(21):3519-29. doi: 10.1007/s00018-011-0797-0. Epub 2011 Sep 6. Review.

16.

Glucose transporters in the uterus: an analysis of tissue distribution and proposed physiological roles.

Frolova AI, Moley KH.

Reproduction. 2011 Aug;142(2):211-20. doi: 10.1530/REP-11-0114. Epub 2011 Jun 3. Review.

17.

Association between p21 Ser31Arg polymorphism and cancer risk: a meta-analysis.

Ma H, Zhou Z, Wei S, Wei Q.

Chin J Cancer. 2011 Apr;30(4):254-63.

18.

Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro.

Benninghoff AD, Bisson WH, Koch DC, Ehresman DJ, Kolluri SK, Williams DE.

Toxicol Sci. 2011 Mar;120(1):42-58. doi: 10.1093/toxsci/kfq379. Epub 2010 Dec 16.

19.

Estrogen-like effects of cadmium in vivo do not appear to be mediated via the classical estrogen receptor transcriptional pathway.

Ali I, Penttinen-Damdimopoulou PE, Mäkelä SI, Berglund M, Stenius U, Akesson A, Håkansson H, Halldin K.

Environ Health Perspect. 2010 Oct;118(10):1389-94. doi: 10.1289/ehp.1001967. Epub 2010 Jun 4.

20.

Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.

Miyajima K, Takekoshi S, Itoh J, Kakimoto K, Miyakoshi T, Osamura RY.

Acta Histochem Cytochem. 2010 May 1;43(2):33-44. doi: 10.1267/ahc.09034. Epub 2010 Apr 7.

Supplemental Content

Support Center